Amedeo Smart

Free Medical Literature Service

 

Amedeo

Biliary Tract Diseases
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. BAGULEY E, Knaub M, VanDyke J, Hirschfield G, et al
    Evaluating the clinical care, quality of life and overall experiences of patients with primary biliary cholangitis (PBC) during the pandemic: A Canadian mixed-methods study.
    PLoS One. 2026;21:e0340475.
    >> Share

  2. ZHANG C, Liang H, Qin Y, Tan X, et al
    A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives.
    PLoS One. 2026;21:e0341154.
    >> Share

  3. PARK Y, Kim KS, Jo H, Kim HP, et al
    Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer.
    PLoS One. 2026;21:e0341432.
    >> Share

  4. CHUEAJEDTON K, Chueaiphuk C, Inpad J, Kumphune S, et al
    Secretory leukocyte protease inhibitor (SLPI) promotes cholangiocarcinoma progression via inflammation-associated and vasculogenic mechanisms.
    PLoS One. 2026;21:e0340763.
    >> Share

  5. FABIAN O, Bajer L, Macinga P, Brezina J, et al
    Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol.
    PLoS One. 2026;21:e0341885.
    >> Share

  6. KITAGATAYA T, Krishnan A, Olson KE, Gutierrez F, et al
    Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury.
    PLoS One. 2026;21:e0342251.
    >> Share

  7. CHEN R, Sun Y, Tai W
    A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis.
    PLoS One. 2026;21:e0342306.
    >> Share

  8. XI J, Wang S, Chen J, Law JCS, et al
    Exploration and discovery of treatment targets for primary biliary cholangitis based on plasma and cerebrospinal fluid proteomics: A multicenter mendelian randomization study.
    PLoS One. 2026;21:e0340166.
    >> Share

  9. ARTBUA P, Kentachalee N, Sitthirak S, Sa-Ngiamwibool P, et al
    Prognostic value of cGAS-STING-IRF3 signaling in cholangiocarcinoma patients.
    PLoS One. 2026;21:e0342756.
    >> Share

  10. LI T, ZhenYu J, Jing W
    Evaluation of the mechanism underlying melatonin action in cholestatic liver disease treatment via network pharmacology, molecular docking, and in vivo experiments.
    PLoS One. 2026;21:e0342978.
    >> Share

  11. IBI Y, Omori T
    Cure rate estimation with insufficient follow-up: A median-based bootstrap correction approach.
    PLoS One. 2026;21:e0344669.
    >> Share

  12. LEI Y, Ma X, Jin X, He Y, et al
    Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-beta1/Smad3 signaling pathway.
    PLoS One. 2026;21:e0344168.
    >> Share

  13. CHOI SJ, Kim HJ, Kwon SW, Kim WS, et al
    Lipidomic analysis of bile from patients with extrahepatic cholangiocarcinoma.
    PLoS One. 2026;21:e0345136.
    >> Share

  14. SORNSENEE P, Chaochuensuk C, Sapsong D, Khongchuy K, et al
    Development and internal validation of a risk stratification scoring system for identifying gram-negative ESBL-positive acute cholangitis: A retrospective cohort study.
    PLoS One. 2026;21:e0345150.
    >> Share

  15. FAN R, Cao X, Long Z, Ma B, et al
    Prevalence and risk factors of cholelithiasis in patients with spinal cord injury: A cross-sectional analysis.
    PLoS One. 2026;21:e0344816.
    >> Share

  16. ALZOUBI M, Omar Saleh A, Omari FA, Shatnawi K, et al
    Asymptomatic gallstones: Cumulative incidence proportion, incidence rate, and risk factors for symptoms development: Systematic review and meta-analysis.
    PLoS One. 2026;21:e0345462.
    >> Share

  17. AOTO K, Inose R, Muraki Y
    Clinical impact of broad- versus narrow-spectrum empiric therapy in acute cholangitis: A Japanese claims database study.
    PLoS One. 2026;21:e0346452.
    >> Share

  18. GOLLA M, Katiganere Siddaramappa H, Venkata Naga Sai PJ, Adla SK, et al
    GBCapsNet: A calibrated capsule network for automated gallbladder disease diagnosis via ultrasound imaging.
    PLoS One. 2026;21:e0348705.
    >> Share

  19. TAHA RO, Chaijaroenkul W, Phompradit P, Na-Bangchang K, et al
    Targeted analysis of KRAS and CREBBP mutations uncovers a potential population-specific signature in thai patients with liver fluke-associated cholangiocarcinoma.
    PLoS One. 2026;21:e0348942.
    >> Share

  20. SAKKA R, Abroug H, Youssef SB, Mekki M, et al
    Types of genotypes in progressive familial intrahepatic cholestasis and liver transplantation: A meta-analysis of observational studies.
    PLoS One. 2026;21:e0350508.
    >> Share

  21. DAS P, Khan MAU, Sarker P, Nahid AA, et al
    Gallstone disease classification using SLOA-optimized CatBoost classifier with explainable AI.
    PLoS One. 2026;21:e0342945.
    >> Share

  22. RAMEZANI R, Rabiei MR, Arashi M
    Integrating preliminary test and Stein-type techniques to improve estimation in the time-dependent Cox model.
    PLoS One. 2026;21:e0345123.
    >> Share

  23. WANCHAITANAWONG W, Phinyo P, Kunlayawutipong T, Chatkul N, et al
    Spontaneous passage of common bile duct stones: predictive factors and impact on post-ERCP complications.
    PLoS One. 2026;21:e0351242.
    >> Share

  24. KIM S, So H, Park HW, Park S, et al
    Association between gallstones and subclinical coronary atherosclerosis: An observational study with propensity score matching.
    PLoS One. 2026;21:e0356142.
    >> Share

  25. FENG J, Liu Z, Sun H
    Integrative bioinformatics analysis identifies gut microbiota-derived metabolite-associated immune candidate targets in high-risk primary biliary cholangitis.
    PLoS One. 2026;21:e0356008.
    >> Share

  26. PHAN NH, Do DK, Pham HC, Nguyen TB, et al
    Percutaneous transhepatic cholangioscopy-guided holmium laser lithotripsy for bile duct stones in elderly patients.
    PLoS One. 2026;21:e0356488.
    >> Share

  27. CHIBA N, Abe Y, Kojima H, Suda R, et al
    The coefficient of variation of CT values for predicting lymph node metastasis in extrahepatic cholangiocarcinoma.
    PLoS One. 2026;21:e0357578.
    >> Share

  28. CISLARU A, Yagmur E, Bannon C, Cremen S, et al
    Dysregulation of the serum and IgG N-glycome in decompensated cirrhosis and its association with Model for End-Stage Liver Disease-Sodium (MELD-Na).
    PLoS One. 2026;21:e0357709.
    >> Share

    January 2025
  29. SUGAWARA I, Kawahara Y, Takayasu L, Isshi K, et al
    Study on the relationship between microbial composition within obstructive biliary stents and the severity of obstruction and duration of stent placement.
    PLoS One. 2025;20:e0317230.
    >> Share

  30. SAWAYA M, Cordina-Duverger E, Lamy PJ, Tretarre B, et al
    Kidney and gallbladder stones and the risk of prostate cancer: Results from the EPICAP study.
    PLoS One. 2025;20:e0317760.
    >> Share

  31. ARMARTMUNTREE N, Kittirat Y, Promraksa B, Loilome W, et al
    Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells.
    PLoS One. 2025;20:e0317111.
    >> Share

  32. THAKUR C, Mahato RK, Marasini S, Timalsena D, et al
    Risk factors of gallbladder cancer in Nepal: A case control study.
    PLoS One. 2025;20:e0317249.
    >> Share

  33. WANG F, Gao Y
    Efficacy of early enteral nutrition support on the nutritional status of patients after gallstone surgery.
    PLoS One. 2025;20:e0314659.
    >> Share

  34. HASAN R, Allahbakhshi F, Shlyk AD, Allahbakhshi K, et al
    Gallstones as a predictor of elevated cardiovascular disease risk: A meta-analysis and meta-regression of over 7.4 million participants.
    PLoS One. 2025;20:e0314661.
    >> Share

  35. ABUBAKR K, Kennedy C, Al-Tikriti S, O'Higgins AC, et al
    Intrahepatic cholestasis of pregnancy and gestational diabetes: Protocol for a scoping review of associations, risk factors, and outcomes.
    PLoS One. 2025;20:e0300076.
    >> Share

  36. GAO C, Liu M, Sun Y, Zhao Z, et al
    Association between advanced lung cancer inflammation index and gallstone prevalence among U.S. adults: A population-based study.
    PLoS One. 2025;20:e0321733.
    >> Share

  37. TIAN L, Guo Q, Fu D, Ma X, et al
    Adjuvant chemotherapy compared with observation in patients with resected biliary tract cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0295583.
    >> Share

  38. SAEHENG T, Tongsiri N, Na-Bangchang K
    The first validation of the Functional Assessment of Cancer Therapy Hepatobiliary (FACT-Hep) for evaluating health-related quality of life (HRQOL) in patients with advanced-stage intrahepatic cholangiocarcinoma (biliary tract cancer).
    PLoS One. 2025;20:e0321618.
    >> Share

  39. YE J, Liu R, Wang J, Ma W, et al
    Association of albumin-bilirubin grade with survival outcomes in patients with cholangiocarcinoma.
    PLoS One. 2025;20:e0321758.
    >> Share

  40. THANYAPHOO S, Sae-Lee C, Thaopech W, Amornrit W, et al
    Transcriptome insights into newcastle disease virus-mediated eradication of cholangiocarcinoma cells.
    PLoS One. 2025;20:e0322307.
    >> Share

  41. WIN ZZ, Dokduang H, Kulwong S, Loilome W, et al
    Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma.
    PLoS One. 2025;20:e0322173.
    >> Share

  42. OLFATIFAR M, Rajabnia M, Sadeghi A, Rabbani A, et al
    The epidemiological trends and projected future of primary sclerosing cholangitis by 2040: An updated meta-analysis and modeling study.
    PLoS One. 2025;20:e0322479.
    >> Share

  43. MARTVISET P, Chantree P, Tongsiri N, Plengsuriyakarn T, et al
    Targeting tumor-associated genes, immune response, and circulating tumor cells in intrahepatic cholangiocarcinoma: Therapeutic potential of Atractylodes lancea (Thunb.) DC.
    PLoS One. 2025;20:e0323732.
    >> Share

  44. INOUE T, Masuda T, Koiso T, Ibusuki M, et al
    Heated-balloon ablation as a novel less invasive local treatment for bile duct strictures: A first experimental study.
    PLoS One. 2025;20:e0322801.
    >> Share

  45. NGAMSANGIAM W, Techa-Ay S, Sa-Ngiamwibool P, Watcharadetwittaya S, et al
    Distinct chromosome abnormality patterns for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2025;20:e0322408.
    >> Share

  46. NOGUCHI D, Kuriyama N, Kozuka Y, Komatubara H, et al
    A recent update on the morphological classification of intraductal papillary neoplasm of the bile duct: Correlation with postoperative prognosis and pathological features.
    PLoS One. 2025;20:e0325081.
    >> Share

  47. SCHACHTSCHNEIDER KM, Redlon LN, Lokken RP, Huang YH, et al
    Epigenetic regulation of individual components of combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2025;20:e0324145.
    >> Share

  48. FAIPAN A, Sitthirak S, Wangwiwatsin A, Namwat N, et al
    Mitochondrial genomic alterations in cholangiocarcinoma cell lines.
    PLoS One. 2025;20:e0323844.
    >> Share

  49. XIONG Z, Sun Q, Huang J, Li F, et al
    Non-linear association of cardiometabolic index with gallstone disease in US adults: A cross-sectional study.
    PLoS One. 2025;20:e0328415.
    >> Share

  50. WANG J, Qi X, Zhao W, Hao Z, et al
    Hsa_circ_0006834 represses intrahepatic cholangiocarcinoma proliferation through activating AMPK-mTOR pathway and autophagy via has-miR-637-NGFR network.
    PLoS One. 2025;20:e0329847.
    >> Share

  51. CHEN X, Huang J, Chen X, Luo Q, et al
    Comparative analysis of differences for pathological upgrade and incomplete resection in endoscopic snare papillectomy for ampullary adenomas: A single-institution retrospective study.
    PLoS One. 2025;20:e0330220.
    >> Share

  52. SHEN W, Liu Y, Dai B, Qin C, et al
    Downregulation of NCOA4 expression indicates poor prognosis and promotes the progression of cholangiocarcinoma.
    PLoS One. 2025;20:e0327722.
    >> Share

  53. LYU C, Meng X, Wang J, Shao H, et al
    Optimized processing of Gardenia Fruits with ginger juice: Unveiling therapeutic mechanisms for cholestatic liver injury through TLR4/NF-kappaB, FXR/PPAR-alpha, and PI3K/AKT/GSK-3beta.
    PLoS One. 2025;20:e0330189.
    >> Share

  54. LI J, Zhou YQ
    Enhanced gallbladder cancer detection via active and self-supervised learning integration: Innovating B-ultrasound image analysis.
    PLoS One. 2025;20:e0330781.
    >> Share

  55. DU C, Wang H, Cao W, Yu Z, et al
    Perioperative and long-term outcomes of laparoscopic liver resection for combined hepatocellular carcinoma and cholangiocarcinoma versus intrahepatic cholangiocarcinoma: A propensity score matching analysis.
    PLoS One. 2025;20:e0328104.
    >> Share

  56. MON AM, Intuyod K, Klungsaeng S, Jusakul A, et al
    A circulating microRNA panel enhances the diagnosis of cholangiocarcinoma.
    PLoS One. 2025;20:e0333279.
    >> Share

  57. TANASUKA P, Thongpon P, Chomwong S, Kongsintaweesuk S, et al
    Suppression of kinesin family member-18A diminishes progression and induces apoptotic cell death of gemcitabine-resistant cholangiocarcinoma cells by modulating PI3K/Akt/mTOR and NF-kappaB pathways.
    PLoS One. 2025;20:e0334147.
    >> Share

  58. SERRI R, Dehneh N, Ghannam M, Sirri MR, et al
    Synergistic effects of sesame oil, extra virgin olive oil, psyllium extract, and dandelion extract on cholesterol gallstone dissolution: An in vitro comparative study against Rowachol(R).
    PLoS One. 2025;20:e0334496.
    >> Share

  59. CHAIDEE A, Kongsintaweesuk S, Pongking T, Tunbenjasiri K, et al
    Minimally invasive detection of early-stage opisthorchiasis-associated cholangiocarcinoma using label-free surface-enhanced Raman spectroscopy (SERS) of hamster serum.
    PLoS One. 2025;20:e0334916.
    >> Share

  60. DAI J, Selvaraj E, Culver EL, Bailey A, et al
    Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis.
    PLoS One. 2025;20:e0335642.
    >> Share

  61. HEINRICH S, Ten Thoren PJ, Behrendt P, Hagenah J, et al
    Dynamic growth risk of incidentally detected gallbladder polyps-A retrospective, single-center analysis.
    PLoS One. 2025;20:e0337890.
    >> Share

    January 2024
  62. LIU Z, Shao Y, Duan X
    Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298225.
    >> Share

  63. DI CARLO P, Serra N, Fasciana TMA, Giammanco A, et al
    Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    PLoS One. 2024;19:e0294049.
    >> Share

  64. BAGER P, Bossen L, Gantzel R, Gronbaek H, et al
    High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial.
    PLoS One. 2024;19:e0301354.
    >> Share

  65. GUPTA K, Xu JP, Diamond T, de Jong IEM, et al
    Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring: Evidence for a spectrum of neonatal injury.
    PLoS One. 2024;19:e0301824.
    >> Share

  66. BEKRIC D, Kiesslich T, Ocker M, Winklmayr M, et al
    The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells.
    PLoS One. 2024;19:e0302050.
    >> Share

  67. ZHOU X, Huang T, Pan H, Du A, et al
    Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma.
    PLoS One. 2024;19:e0300441.
    >> Share

  68. KIM SH, Lee S
    Determining the patency of biliary tracts in dogs with gallbladder mucocele using near-infrared cholangiography with indocyanine green.
    PLoS One. 2024;19:e0300395.
    >> Share

  69. HUANG X, Gu H, Shen P, Zhang X, et al
    Systematic review and meta-analysis: Evaluating the influence of intrahepatic cholestasis of pregnancy on obstetric and neonatal outcomes.
    PLoS One. 2024;19:e0304604.
    >> Share

  70. ALI K, Chervu NL, Sakowitz S, Bakhtiyar SS, et al
    Interhospital variation in the nonoperative management of acute cholecystitis.
    PLoS One. 2024;19:e0300851.
    >> Share

  71. GOOKIN JL, Jewell DE, Aicher KM, Seiler GS, et al
    Increased lipogenesis and lipidosis of gallbladder epithelium in dogs with gallbladder mucocele formation.
    PLoS One. 2024;19:e0303191.
    >> Share

  72. KERDKUMTHONG K, Nanarong S, Roytrakul S, Pitakpornpreecha T, et al
    Quantitative proteomics analysis reveals possible anticancer mechanisms of 5'-deoxy-5'-methylthioadenosine in cholangiocarcinoma cells.
    PLoS One. 2024;19:e0306060.
    >> Share

  73. LI L, Liu C, Xia T, Li H, et al
    Association between plant-based dietary index and gallstone disease: A cross sectional study from NHANES.
    PLoS One. 2024;19:e0305822.
    >> Share

  74. TANG G, Nierath WF, Leitner E, Xie W, et al
    Comparing animal well-being between bile duct ligation models.
    PLoS One. 2024;19:e0303786.
    >> Share

  75. MANTAS A, Otto CC, Olthof PB, Heise D, et al
    Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma.
    PLoS One. 2024;19:e0304838.
    >> Share

  76. HAN X, Wang J, Wu Y, Gu H, et al
    Predictive value of bile acids as metabolite biomarkers for gallstone disease: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0305170.
    >> Share

  77. KATSUMI T, Sato H, Murakami R, Hanatani T, et al
    Identification of microbial antigens in liver tissues involved in the pathogenesis of primary biliary cholangitis using 16S rRNA metagenome analysis.
    PLoS One. 2024;19:e0308912.
    >> Share

  78. GOPAL SH, Zebda R, Mohan A, Borovsky K, et al
    Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307837.
    >> Share

  79. WATAD H, Ohayon A, Meyer R, Cohen A, et al
    Proteinuria is a clinical characteristic of intrahepatic cholestasis of pregnancy but it is not a marker of severity: A retrospective cohort study.
    PLoS One. 2024;19:e0310217.
    >> Share

  80. PANYA A, Wathikthinnakon M, Thepmalee C, Chiawpanit C, et al
    Polysaccharide extract of Spirulina sp. increases effector immune-cell killing activities against cholangiocarcinoma.
    PLoS One. 2024;19:e0312414.
    >> Share

  81. WANG T, Xie R, Jiang C, Chen L, et al
    Associations between Life's Essential 8 and gallstones among US adults: A cross-sectional study from NHANES 2017-2018.
    PLoS One. 2024;19:e0312857.
    >> Share

  82. LI X, Wang J, Leng K
    Lipid accumulation product and gallstone risk in US adults: A cross-sectional analysis of NHANES 2017-2020 data.
    PLoS One. 2024;19:e0315235.
    >> Share

  83. YU S, Kang M, Yoo Y, Kim TY, et al
    Characterization of an Enterococcus sp. SMC-9 strain isolated from bile of a patient with cholangitis.
    PLoS One. 2024;19:e0312953.
    >> Share

  84. ANGENDOHR C, Missing L, Ehlting C, Wolf SD, et al
    Interleukin 1 beta suppresses bile acid-induced BSEP expression via a CXCR2-dependent feedback mechanism.
    PLoS One. 2024;19:e0315243.
    >> Share

  85. SAHAT O, Kamsa-Ard S, Suwannatrai AT, Lim A, et al
    Spatial analysis of cholangiocarcinoma in Thailand from 2012 to 2021; a population-based cancer registries study.
    PLoS One. 2024;19:e0311035.
    >> Share

    January 2023
  86. ZHOU T, Wei H, Wang J
    Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid.
    PLoS One. 2023;18:e0279431.
    >> Share

  87. WONGKANONG C, Patumanond J, Ratanachu-Ek T, Junrungsee S, et al
    Development of clinical prediction rule for the requirement of endoscopic papillary large balloon dilation (EPLBD) on endoscopic CBD stone clearance.
    PLoS One. 2023;18:e0282899.
    >> Share

  88. INOUE T, Kutsumi H, Ibusuki M, Yoneda M, et al
    Endoscopic biliary ethanol ablation using a novel multi-hole balloon catheter: In vivo feasibility study in a swine model.
    PLoS One. 2023;18:e0283733.
    >> Share

  89. YANG S, Qin L, Wu P, Liu Y, et al
    RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation.
    PLoS One. 2023;18:e0283770.
    >> Share

  90. YE Y, Lui VCH, Babu RO, Wu Z, et al
    Identification of cancer-related genes FGFR2 and CEBPB in choledochal cyst via RNA sequencing of patient-derived liver organoids.
    PLoS One. 2023;18:e0283737.
    >> Share

  91. HAN X, Wang J, Wu Y, Gu H, et al
    Predictive value of bile acids as metabolite biomarkers for gallstones: A protocol of systematic review and meta-analysis.
    PLoS One. 2023;18:e0284138.
    >> Share

  92. POUDEL SK, Padmanabhan R, Dave H, Guinta K, et al
    Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease.
    PLoS One. 2023;18:e0283021.
    >> Share

  93. JANNONE G, de Magnee C, Tambucci R, Evraerts J, et al
    Premature senescence of the liver in Alagille patients.
    PLoS One. 2023;18:e0285019.
    >> Share

  94. KIM MH, Lee EJ, Kim SJ, Jung YJ, et al
    Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression.
    PLoS One. 2023;18:e0287146.
    >> Share

  95. SIDDIQUI MA, Dwivedi N, Siddiqui MH, Rana SV, et al
    NMR spectroscopy-based analysis of gallstones of cancerous and benign gallbladders from different geographical regions of the Indian subcontinent.
    PLoS One. 2023;18:e0286979.
    >> Share

  96. MAYR C, Kiesslich T, Bekric D, Beyreis M, et al
    Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.
    PLoS One. 2023;18:e0287769.
    >> Share

  97. NEROLDOVA M, Ciara E, Slatinska J, Frankova S, et al
    Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.
    PLoS One. 2023;18:e0288907.
    >> Share

  98. KUNIYOSHI N, Imazu H, Masuzaki R, Yamazaki M, et al
    Diagnostic utility of quantitative analysis of microRNA in bile samples obtained during endoscopic retrograde cholangiopancreatography for malignant biliary strictures.
    PLoS One. 2023;18:e0289537.
    >> Share

  99. IWAMOTO T, Suda T, Inoue T, Nozaki Y, et al
    Postoperative bleeding after percutaneous transhepatic gallbladder drainage and aspiration in patients receiving antithrombotic therapy.
    PLoS One. 2023;18:e0288463.
    >> Share

  100. SHEARN CT, Anderson AL, Devereaux MW, El Kasmi KC, et al
    Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition.
    PLoS One. 2023;18:e0290385.
    >> Share

  101. GOINS EC, Wein LE, Watkins VY, Campbell AIK, et al
    Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts.
    PLoS One. 2023;18:e0293030.
    >> Share

  102. PHAM HN, Pham L, Sato K
    Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
    PLoS One. 2023;18:e0292998.
    >> Share

  103. HAYASHI H, Shimizu A, Kubota K, Notake T, et al
    Impact of sarcopenic obesity on post-hepatectomy bile leakage for hepatocellular carcinoma.
    PLoS One. 2023;18:e0286353.
    >> Share

  104. YUK JS, Park JY
    Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
    PLoS One. 2023;18:e0294356.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016